Treatment of disseminated superficial actinic porokeratosis with oral alitretinoin.

Park, B J; Oh, E H; Kim, J E; Ko, J Y; Ro, Y S

Park, B J; Oh, E H; Kim, J E; Ko, J Y; Ro, Y S.

Affiliation

Park BJ; Department of Dermatology, College of Medicine, University of Hanyang, Seoul, Korea.
Oh EH; Department of Dermatology, College of Medicine, University of Hanyang, Seoul, Korea.
Kim JE; Department of Dermatology, College of Medicine, University of Hanyang, Seoul, Korea.
Ko JY; Department of Dermatology, College of Medicine, University of Hanyang, Seoul, Korea.
Ro YS; Department of Dermatology, College of Medicine, University of Hanyang, Seoul, Korea.

J Eur Acad Dermatol Venereol ; 31(11): e505-e507, 2017 Nov.

Article in En | MEDLINE | ID: mdl-28543730

Subject(s)

Alitretinoin/therapeutic use; Dermatologic Agents/therapeutic use; Porokeratosis/drug therapy; Administration, Oral; Adult; Aged; Female; Humans; Male; Porokeratosis/pathology

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Porokeratosis / Dermatologic Agents / Alitretinoin Limits: Adult / Aged / Female / Humans / Male Language: En Year: 2017 Type: Article

Fulltext

XML

PubMed Links

Search on Google